Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • LUV vs GSK✓SelectedUSD · GSKLUV vs GSK performance historyLatest closeAs of-3.10%11/19
Stock and ETF performance explorer

LUV vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+9.0%
GSK return
+97.7%
Excess return
-88.6%
Maximum drawdown
-64.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.1%-1.6%-1.5%-2.5%
7D+0.8%-4.7%+5.6%+2.6%
30D+15.0%-4.7%+19.7%+17.1%
3M+10.6%-8.8%+19.4%+14.2%
6M+23.2%-4.6%+27.9%+24.8%
YTD+11.8%+1.0%+10.8%+11.2%
1Y+45.4%+6.9%+38.6%+41.8%
3Y+96.0%+52.5%+43.4%+61.1%
5Y+6.1%+40.3%-34.2%-11.3%
All+9.0%+97.7%-88.6%-19.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling